글로벌 제약 블리스터 포장 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모

지난 10년 동안 글로벌 시장 환경은 극적으로 바뀌었고 이 기간은 제약 산업에 매우 중요했습니다. 1990년대 중반까지 미국, 유럽, 일본은 세계 API(Active Pharmaceutical Ingredients)의 90%를 공급했습니다. 그러나 지난 10년 동안 변화하는 시장 클러스터, 무역 문제, 제조 기반 이동으로 인해 초점이 아시아 태평양 지역으로 옮겨갔습니다. 최근 연구에 따르면 중국은 전 세계 모든 API의 40% 이상을 제조하지만 인도와 중국이 주요 공급원으로 미국으로의 API 수입의 75% 이상을 차지합니다.

• 글로벌 제약 블리스터 포장 시장은 2021년에 65억 5천만 달러로 평가되었으며, 2029년까지 103억 9천만 달러에 도달할 것으로 예상되며, 2022-2029년 예측 기간 동안 5.60%의 CAGR을 기록할 것으로 예상됩니다. "폴리염화비닐(PVC)"은 가볍고, 저렴하며, 뛰어난 차단 특성과 불활성 특성으로 인해 제약 블리스터 포장 시장에서 가장 큰 소재 세그먼트를 차지합니다.

시장 정의

제약 제품의 포장은 필수적인 구성 요소입니다. 포장은 제약 제품의 분배, 투여 및 관리에 자주 사용됩니다. 블리스터 포장은 제약 산업에서 가장 내구성 있는 포장 유형으로, 다양한 제약 제품을 공기, 습도 및 습기와 같은 요인으로부터 보호하여 이러한 요인과 접촉하면 오염을 일으킬 수 있습니다. 약물을 보호하고, 복용량 준수를 개선하며, 제품 디자인에 맞게 쉽게 사용자 정의할 수 있기 때문에 인기가 높습니다.

Pharmaceutical Blister Packaging Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

• Growing Awareness Associated with Blister Packaging 

The blister packaging basically protects medication, improves dosage compliance, and can be easily customized to fit as per the product design, which is projected to accelerate the market's growth. The packaging protects various pharmaceutical products from factors including air, humidity, and moisture as contact of the products with these factors can lead to contamination, further boosting demand for the market.

• Development and Advancements

Furthermore, increase in product innovations, growing use of the smart packaging for patient engagement and identification and merger and acquisition to support new demands are other market growth determinants. Advanced manufacturing processes to develop sustainable and eco-friendly packaging solutions also extend profitable opportunities to the market players in the forecast period of 2022 to 2029.

The rising geriatric population and increasing incident of chronic conditions, pushing the demand for new and effective pharmaceutical products carve the way for market's expansion. Additionally, increase in patient-oriented medicines, including biologics will bolster the growth of the market. Surging urbanization, higher economic growth and improvements in the quality of life, will further expand the future growth of the pharmaceutical blister packaging market. 

Restraints/Challenges

• Price Volatility to Restrict Growth of Market

The price volatility of raw materials will create hindrances for the growth of the pharmaceutical blister packaging market.

• Stringent Government Regulations

The stringent government regulations and standard also challenge the pharmaceutical blister packaging market. Furthermore, the pandemic crisis results in lack of workforce, transportation restrictions, and shortage in raw materials and implementation of lockdown across the globe, which hampered the growth of market.

The lack of access and awareness in the emerging market is projected to hurdle the market's growth.

This pharmaceutical blister packaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pharmaceutical blister packaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post COVID-19 Impact on Pharmaceutical Blister Packaging Market

The recent outbreak of coronavirus has critically impacted the various sectors across the globe. The materials and packaging sector was also grievously hit by the pandemic. The various lockdown and social distancing restrictions led to the large-scale disruptions in the supply chain, shortage of workers, transportation restrictions and raw material shortages resulting in downfall in the demand for pharmaceutical blister packaging.

However, the vaccines require different administration routes (e.g., inhaled, oral, transdermal, and injectable), demand for primary packaging can be extended across multiple packaging formats after vaccine approval. As a result, COVID-19 is expected to drive pharmaceutical packaging growth over the forecast period.

Recent Development

• In April 2020, Schott AG a German pharmaceutical glass manufacturer, introduced smart containers, which are laser-marked with a unique identifier to create robust traceability throughout the manufacturing process. The company has entered the digitised pharma manufacturing space. Every Smart Container is marked with a laser and a unique identifier, allowing for unprecedented traceability throughout the manufacturing process. The new concept allows pharma manufacturers to harness the power of machine vision and big data analytics on pharmaceutical filling lines. According to the German company, the new technology can be used to improve reject management and line clearance. It also lowers the chance of a mix-up, improves lyophilization processes, and facilitates container-based targeted recalls.

Global Pharmaceutical Blister Packaging Market Scope

The pharmaceutical blister packaging market is segmented on the basis of product type, technology type, material and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Clamshell
• Carded

On the basis of product type, the pharmaceutical blister packaging market has been segmented into clamshell and carded.

Technology Type

• Cold Forming
• Thermoforming

On the basis of technology type, the pharmaceutical blister packaging market has been segmented into cold forming and thermoforming.

Material

• Polyethylene Terephthalate,
• High Density Polyethylene (HDPE)
• Polyvinyl Chloride (PVC)
• Low Density Polyethylene (LDPE)
• Aluminum
• Paper and Paper Board

The pharmaceutical blister packaging market has also been segmented on the basis of material into polyethylene terephthalate, high density polyethylene (HDPE), polyvinyl chloride (PVC), low density polyethylene (LDPE), aluminum, paper and paper board. Polyethylene terephthalate includes PET, PETE, PETG or Polyester. Polyvinyl chloride (PVC) is the highest growing segment as compared to other materials as it the most popular raw material and is used owing to its light weight, low cost, excellent barrier properties and inert nature.

Application

• Tablets
• Capsules
• Powders
• Medical Devices

On the basis of application, the pharmaceutical blister packaging market is segmented into tablets, capsules, powders and medical devices.

Pharmaceutical Blister Packaging Market Regional Analysis/Insights

The pharmaceutical blister packaging market is analyzed and market size insights and trends are provided by country, product type, technology type, material and application as referenced above.

The countries covered in the pharmaceutical blister packaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the pharmaceutical blister packaging market because of the presence of major pharmaceutical companies, availability of advanced technological research platforms and the increasing funding towards research and development.

On the other hand, Asia-Pacific is estimated to register a significant growth due to the increasing pharmaceutical production, a sizeable patient pool, rising consumer awareness, and the need for novel packaging materials.

보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규제의 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 추세 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

경쟁 환경 및 제약용 블리스터 포장 시장 점유율 분석

제약 블리스터 포장 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 제약 블리스터 포장 시장과 관련된 회사의 초점에만 관련이 있습니다.

제약품 블리스터 포장 시장의 주요 기업으로는 Schott(독일), Amcor plc(스위스), Dow(미국), AptarGroup, Inc.(미국), Klöckner Pentaplast(독일), West Pharmaceutical Services, Inc.(미국), Berry Global Inc.(미국), Honeywell International, Inc.(미국), ACG(인도), Nipro(일본), Gerresheimer AG(독일), Catalent Inc.(미국), WestRock Company(미국) 등이 있습니다.

SKU-54511